Antibiotic Resistance and Antibiotic Use in 2025
Key Points
A notable decline in antibiotic use is observed in 2025 compared to 2024
- In healthcare facilities, overall antibiotic use decreased by 4%.
- In outpatient care, antibiotic use fell by 9.6%.
- In the outpatient sector, for the first time, the analyses highlight prescriptions by pharmacists (1%), linked to the use of rapid diagnostic tests (RDTs) in pharmacies.
Mixed trends in bacterial resistance in 2025
- In outpatient settings and long-term care facilities, resistance to third-generation cephalosporins (3GC) in Escherichia coli is rising to 5.1% and 10%, respectively, and the proportion of carbapenemase-producing Enterobacteriaceae is also increasing to 0.084% and 0.125%, respectively.
- In contrast, resistance to fluoroquinolones (FQ) has decreased, standing at 9% in the community and 11.6% in long-term care facilities.
- In healthcare facilities, the incidence rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-producing Enterobacteriaceae) remained stable (0.58 per 1,000 patient-days), while that of carbapenemase-producing Enterobacteriaceae (CPE) rose sharply, reaching 0.041 per 1,000 patient-days—a 310% increase since 2019.
Noteworthy increase in surveillance participation
- 1,620 healthcare facilities (compared to 1,392 in 2024) participated in antibiotic use surveillance, covering 83% of hospital days in France.
- In outpatient care, participation by clinical laboratories increased, rising from 44.6% in 2024 to 52.4% in 2025.
In total:
- The results show an encouraging trend in antibiotic use in France in 2025 and over the 2015–2025 period.
- Regarding antibiotic resistance, the rise in EBLSE and, even more so, in EPC across all healthcare sectors remains a cause for concern and confirms the need to strengthen strategies for infection prevention and the appropriate use of antibiotics.
In relation to
Our latest news
news
Call for Nominations to Fill Vacancies on the National Reference Centers...
news
Public Health France Conference: November 9, 2026
news